InteRNA is a Dutch biotechnology company specializing in the development of RNA therapeutics for the treatment of cancer. Founded in 2006 as a spin-off from the Hubrecht Institute, the Company became operational early 2008 and took an unbiased approach in R&D focusing on the elucidation of the functional roles of miRNAs to allow innovative development of miRNA-based therapeutics for cancer.
In 2009, InteRNA moved to its own offices and laboratories at the Uithof campus in Utrecht, near the Hubrecht Institute, Utrecht Medical Center and Utrecht University.
InteRNA has its statutory seat in Nijmegen (NL).
InteRNA Technologies aspires to improve cancer therapy effectiveness through innovative, intelligent miRNA-based therapeutics.